Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPMR.L Regulatory News (PMR)

  • There is currently no data for PMR

Rule 8 statement re Panmure Gordon & Co plc

23 Sep 2010 16:44

RNS Number : 2269T
Evolution Group PLC
23 September 2010
 



The Evolution Group Plc

23 September 2010

THE EVOLUTION GROUP PLC

For Immediate Release

Evolution Group Plc ("Evolution" or the "Company")

Rule 8 statement relating to Panmure Gordon & Co plc ("Panmure Gordon")

Further to its announcement earlier today, Evolution provides the following information in relation to the requirements of Rule 8 of the City Code on Takeovers and Mergers (the "Code").

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any paper offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any paper offeror is first identified.

An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any paper offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a paper offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any paper offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any paper offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a paper offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

In accordance with Rule 2.10 of the Code, the Company announces that at the close of business on 22 September 2010, the Company had the following relevant securities (as defined under the Code) in issue and admitted to the official list and to trading on the main market of the London Stock Exchange: 232,289,024 ordinary shares of one pence each. The ISIN reference number for these securities is GB0030221864.

For Enquiries:

 

Evolution

Alex Snow, Chief Executive Officer 0207 071 4300

 

Investor Relations

Charles Cooke, Director Merlin Financial 0207 726 8400

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRKKNDQPBKDKCB
Date   Source Headline
3rd May 20169:41 amRNSAppointment of Non-Executive Chairman
25th Apr 20161:58 pmBUSNotice of AGM
21st Apr 20162:54 pmBUSHolding(s) in Company
21st Apr 20161:05 pmBUSHolding(s) in Company
14th Apr 201611:07 amBUSEBT trading plan
5th Apr 201612:55 pmBUSFinal Results
31st Mar 20163:12 pmBUSHolding(s) in Company
31st Mar 20167:00 amRNSFinal Results
17th Mar 201611:39 amBUSHolding(s) in Company
24th Feb 20167:17 amRNSBoard Change and Shareholder Financing
17th Feb 20167:00 amRNSDirectorate change
3rd Feb 201611:06 amBUSHolding(s) in Company
1st Feb 20162:13 pmBUSDirectorate Change
11th Jan 20161:56 pmBUSHolding(s) in Company
23rd Dec 20157:00 amRNSTrading Update
9th Dec 20157:00 amBUSHolding(s) in Company
4th Nov 20153:09 pmBUSHolding(s) in Company
23rd Oct 20152:06 pmBUSEBT trading plan - Replacement
22nd Oct 20156:04 pmBUSEBT Trading Plan
19th Oct 201511:59 amRNSForm 8.3 - Zwanziger Family Ventures LLC
7th Oct 20153:55 pmBUSHolding(s) in Company
1st Oct 20155:04 pmRNSForm 8.3 - EKF Diagnostics Holdings PLC
30th Sep 20154:37 pmBUSHolding(s) in Company
29th Sep 20157:00 amBUSHalf-yearly Report
9th Sep 201511:57 amBUSHolding(s) in Company
28th Aug 201510:46 amRNSForm 8.3 - EKF Diagnostics Holdings plc
27th Aug 20151:22 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
26th Aug 20154:27 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
26th Aug 20154:27 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
10th Aug 201511:47 amBUSHolding(s) in Company
15th Jul 20158:19 amBUSAcquisition
8th Jul 201510:20 amBUSHolding(s) in Company
17th Jun 20154:44 pmBUSAcquisition
8th Jun 20154:11 pmBUSHolding(s) in Company
20th May 20152:13 pmBUSHolding(s) in Company
18th May 20152:19 pmBUSResult of AGM
18th May 20157:00 amRNSAGM Statement
6th May 20153:00 pmBUSProposed Purchase of Charles Stanley Securities - Replacement
6th May 20152:11 pmBUSProposed Purchase of Charles Stanley Securities
23rd Apr 20152:33 pmBUSNotice of AGM
22nd Apr 20154:54 pmBUSHolding(s) in Company
20th Apr 20153:17 pmBUSEBT Trading Plan
9th Apr 20155:10 pmRNSDealings by Directors and PDMRs
2nd Apr 20151:18 pmRNSNotification Of Major Interest In Shares
27th Mar 20158:44 amBUSFinal Results
24th Mar 20153:28 pmBUSDividend Declaration Timetable Amendment
24th Mar 20159:41 amBUSDirectorate Change
24th Mar 20157:00 amBUSFinal Results
17th Mar 20157:00 amRNSNotification of Preliminary Results
13th Mar 20154:25 pmBUSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.